This public use dataset has 11 data elements reflecting United States COVID-19 community levels for all available counties. This dataset contains the same values used to display information available on the COVID Data Tracker at: https://covid.cdc.gov/covid-data-tracker/#county-view?list_select_state=all_states&list_select_county=all_counties&data-type=CommunityLevels The data are updated weekly.

CDC looks at the combination of three metrics — new COVID-19 admissions per 100,000 population in the past 7 days, the percent of staffed inpatient beds occupied by COVID-19 patients, and total new COVID-19 cases per 100,000 population in the past 7 days — to determine the COVID-19 community level. The COVID-19 community level is determined by the higher of the new admissions and inpatient beds metrics, based on the current level of new cases per 100,000 population in the past 7 days. New COVID-19 admissions and the percent of staffed inpatient beds occupied represent the current potential for strain on the health system. Data on new cases acts as an early warning indicator of potential increases in health system strain in the event of a COVID-19 surge. Using these data, the COVID-19 community level is classified as low, medium, or high. COVID-19 Community Levels can help communities and individuals make decisions based on their local context and their unique needs. Community vaccination coverage and other local information, like early alerts from surveillance, such as through wastewater or the number of emergency department visits for COVID-19, when available, can also inform decision making for health officials and individuals.

See https://www.cdc.gov/coronavirus/2019-ncov/science/community-levels.html for more information.

For the most accurate and up-to-date data for any county or state, visit the relevant health department website. COVID Data Tracker may display data that differ from state and local websites. This can be due to differences in how data were collected, how metrics were calculated, or the timing of web updates.

For more details on the Minnesota Department of Health COVID-19 thresholds, see COVID-19 Public Health Risk Measures: Data Notes (Updated 4/13/22). https://mn.gov/covid19/assets/phri_tcm1148-434773.pdf

Note: This dataset was renamed from "United States COVID-19 Community Levels by County as Originally Posted" to "United States COVID-19 Community Levels by County" on March 31, 2022. March 31, 2022: Column name for county population was changed to “county_population”. No change was made to the data points previous released. March 31, 2022: New column, “health_service_area_population”, was added to the dataset to denote the total population in the designated Health Service Area based on 2019 Census estimate. March 31, 2022: FIPS codes for territories American Samoa, Guam, Commonwealth of the Northern Mariana Islands, and United States Virgin Islands were re-formatted to 5-digit numeric for records released on 3/3/2022 to be consistent with other records in the dataset. March 31, 2022: Changes were made to the text fields in variables “county”, “state”, and “health_service_area” so the formats are consistent across releases. March 31, 2022: The “%” sign was removed from the text field in column “covid_inpatient_bed_utilization”. No change was made to the data. As indicated in the column description, values in this column represent the percentage of staffed inpatient beds occupied by COVID-19 patients (7-day average). March 31, 2022: Data values for columns, “county_population”, “health_service_area_number”, and “health_service_area” were backfilled for records released on 2/24/2022. These columns were added since the week of 3/3/2022, thus the values were previously missing for records released the week prior. April 7, 2022: Updates made to data released on 3/24/2022 for Guam, Commonwealth of the Northern Mariana Islands, and United States Virgin Islands to correct a data mapping error.

As of March 10, 2023, the death rate from COVID-19 in the state of New York was 397 per 100,000 people. New York is one of the states with the highest number of COVID-19 cases.

The New York Times is releasing a series of data files with cumulative counts of coronavirus cases in the United States, at the state and county level, over time. We are compiling this time series data from state and local governments and health departments in an attempt to provide a complete record of the ongoing outbreak.

Since late January, The Times has tracked cases of coronavirus in real time as they were identified after testing. Because of the widespread shortage of testing, however, the data is necessarily limited in the picture it presents of the outbreak.

We have used this data to power our maps and reporting tracking the outbreak, and it is now being made available to the public in response to requests from researchers, scientists and government officials who would like access to the data to better understand the outbreak.

The data begins with the first reported coronavirus case in Washington State on Jan. 21, 2020. We will publish regular updates to the data in this repository.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases among people who received additional or booster doses were reported from 31 jurisdictions; 30 jurisdictions also reported data on deaths among people who received one or more additional or booster dose; 28 jurisdictions reported cases among people who received two or more additional or booster doses; and 26 jurisdictions reported deaths among people who received two or more additional or booster doses. This list will be updated as more jurisdictions participate. Incidence rate estimates: Weekly age-specific incidence rates by vaccination status were calculated as the number of cases or deaths divided by the number of people vaccinated with a primary series, overall or with/without a booster dose (cumulative) or unvaccinated (obtained by subtracting the cumulative number of people vaccinated with a primary series and partially vaccinated people from the 2019 U.S. intercensal population estimates) and multiplied by 100,000. Overall incidence rates were age-standardized using the 2000 U.S. Census standard population. To estimate population counts for ages 6 months through 1 year, half of the single-year population counts for ages 0 through 1 year were used. All rates are plotted by positive specimen collection date to reflect when incident infections occurred. For the primary series analysis, age-standardized rates include ages 12 years and older from April 4, 2021 through December 4, 2021, ages 5 years and older from December 5, 2021 through July 30, 2022 and ages 6 months and older from July 31, 2022 onwards. For the booster dose analysis, age-standardized rates include ages 18 years and older from September 19, 2021 through December 25, 2021, ages 12 years and older from December 26, 2021, and ages 5 years and older from June 5, 2022 onwards. Small numbers could contribute to less precision when calculating death rates among some groups. Continuity correction: A continuity correction has been applied to the denominators by capping the percent population coverage at 95%. To do this, we assumed that at least 5% of each age group would always be unvaccinated in each jurisdiction. Adding this correction ensures that there is always a reasonable denominator for the unvaccinated population that would prevent incidence and death rates from growing unrealistically large due to potential overestimates of vaccination coverage. Incidence rate ratios (IRRs): IRRs for the past one month were calculated by dividing the average weekly incidence rates among unvaccinated people by that among people vaccinated with a primary series either overall or with a booster dose. Publications: Scobie HM, Johnson AG, Suthar AB, et al. Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1284–1290. Johnson AG, Amin AB, Ali AR, et al. COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021. MMWR Morb Mortal Wkly Rep 2022;71:132–138. Johnson AG, Linde L, Ali AR, et al. COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination — 24 U.S. Jurisdictions, October 3, 2021–December 24, 2022. MMWR Morb Mortal Wkly Rep 2023;72:145–152. Johnson AG, Linde L, Payne AB, et al. Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months — 20 U.S. Jurisdictions, September 18, 2022–April 1, 2023. MMWR Morb Mortal Wkly Rep 2023;72:667–669.

As of March 10, 2023, there have been 1.1 million deaths related to COVID-19 in the United States. There have been 101,159 deaths in the state of California, more than any other state in the country – California is also the state with the highest number of COVID-19 cases.

The vaccine rollout in the U.S. Since the start of the pandemic, the world has eagerly awaited the arrival of a safe and effective COVID-19 vaccine. In the United States, the immunization campaign started in mid-December 2020 following the approval of a vaccine jointly developed by Pfizer and BioNTech. As of March 22, 2023, the number of COVID-19 vaccine doses administered in the U.S. had reached roughly 673 million. The states with the highest number of vaccines administered are California, Texas, and New York.

Vaccines achieved due to work of research groups Chinese authorities initially shared the genetic sequence to the novel coronavirus in January 2020, allowing research groups to start studying how it invades human cells. The surface of the virus is covered with spike proteins, which enable it to bind to human cells. Once attached, the virus can enter the cells and start to make people ill. These spikes were of particular interest to vaccine manufacturers because they hold the key to preventing viral entry.

France Balance of Payment (BoP): Current Account (CA) data was reported at -7,489.000 EUR mn in Feb 2025. This records a decrease from the previous number of -5,808.000 EUR mn for Jan 2025. France Balance of Payment (BoP): Current Account (CA) data is updated monthly, averaging -1,485.000 EUR mn from Jan 2008 (Median) to Feb 2025, with 206 observations. The data reached an all-time high of 15,063.000 EUR mn in Dec 2024 and a record low of -12,115.000 EUR mn in May 2022. France Balance of Payment (BoP): Current Account (CA) data remains active status in CEIC and is reported by Banque de France. The data is categorized under Global Database’s France – Table FR.JB002: BPM6: Balance of Payments: Current Account. [COVID-19-IMPACT]

Population: Manipur data was reported at 3.238 Person mn in 2024. This records an increase from the previous number of 3.209 Person mn for 2023. Population: Manipur data is updated yearly, averaging 2.709 Person mn from Mar 1994 (Median) to 2024, with 31 observations. The data reached an all-time high of 3.514 Person mn in 2021 and a record low of 1.952 Person mn in 1994. Population: Manipur data remains active status in CEIC and is reported by Ministry of Statistics and Programme Implementation. The data is categorized under Global Database’s India – Table IN.GBG001: Population. [COVID-19-IMPACT]

Population: Meghalaya data was reported at 3.425 Person mn in 2025. This records an increase from the previous number of 3.394 Person mn for 2024. Population: Meghalaya data is updated yearly, averaging 2.830 Person mn from Mar 1994 (Median) to 2025, with 32 observations. The data reached an all-time high of 3.425 Person mn in 2025 and a record low of 1.899 Person mn in 1994. Population: Meghalaya data remains active status in CEIC and is reported by Ministry of Statistics and Programme Implementation. The data is categorized under Global Database’s India – Table IN.GBG001: Population. [COVID-19-IMPACT]

Population: Uttar Pradesh data was reported at 237.082 Person mn in 2024. This records an increase from the previous number of 234.692 Person mn for 2023. Population: Uttar Pradesh data is updated yearly, averaging 192.325 Person mn from Mar 1994 (Median) to 2024, with 31 observations. The data reached an all-time high of 237.082 Person mn in 2024 and a record low of 140.030 Person mn in 1994. Population: Uttar Pradesh data remains active status in CEIC and is reported by Ministry of Statistics and Programme Implementation. The data is categorized under Global Database’s India – Table IN.GBG001: Population. [COVID-19-IMPACT]

Population: Madhya Pradesh data was reported at 88.212 Person mn in 2025. This records an increase from the previous number of 87.180 Person mn for 2024. Population: Madhya Pradesh data is updated yearly, averaging 70.005 Person mn from Mar 1994 (Median) to 2025, with 32 observations. The data reached an all-time high of 88.212 Person mn in 2025 and a record low of 51.547 Person mn in 1994. Population: Madhya Pradesh data remains active status in CEIC and is reported by Ministry of Statistics and Programme Implementation. The data is categorized under Global Database’s India – Table IN.GAA001: Population. [COVID-19-IMPACT]

Population: Puducherry data was reported at 1.704 Person mn in 2025. This records an increase from the previous number of 1.667 Person mn for 2024. Population: Puducherry data is updated yearly, averaging 1.134 Person mn from Mar 1994 (Median) to 2025, with 32 observations. The data reached an all-time high of 1.704 Person mn in 2025 and a record low of 0.848 Person mn in 1994. Population: Puducherry data remains active status in CEIC and is reported by Ministry of Statistics and Programme Implementation. The data is categorized under Global Database’s India – Table IN.GBG001: Population. [COVID-19-IMPACT]

Australia Export: Value: FOB: Japan data was reported at 5,416.000 AUD mn in Mar 2025. This records an increase from the previous number of 5,252.000 AUD mn for Feb 2025. Australia Export: Value: FOB: Japan data is updated monthly, averaging 2,590.000 AUD mn from Jan 1988 (Median) to Mar 2025, with 447 observations. The data reached an all-time high of 11,251.000 AUD mn in Sep 2022 and a record low of 791.000 AUD mn in Feb 1989. Australia Export: Value: FOB: Japan data remains active status in CEIC and is reported by Australian Bureau of Statistics. The data is categorized under Global Database’s Australia – Table AU.JA015: Exports: by Country. [COVID-19-IMPACT]

Population: Rajasthan data was reported at 82.406 Person mn in 2025. This records an increase from the previous number of 81.534 Person mn for 2024. Population: Rajasthan data is updated yearly, averaging 65.755 Person mn from Mar 1994 (Median) to 2025, with 32 observations. The data reached an all-time high of 82.406 Person mn in 2025 and a record low of 46.874 Person mn in 1994. Population: Rajasthan data remains active status in CEIC and is reported by Ministry of Statistics and Programme Implementation. The data is categorized under Global Database’s India – Table IN.GBG001: Population. [COVID-19-IMPACT]

Population: Arunachal Pradesh data was reported at 1.569 Person mn in 2024. This records an increase from the previous number of 1.555 Person mn for 2023. Population: Arunachal Pradesh data is updated yearly, averaging 1.309 Person mn from Mar 1994 (Median) to 2024, with 31 observations. The data reached an all-time high of 1.569 Person mn in 2024 and a record low of 0.930 Person mn in 1994. Population: Arunachal Pradesh data remains active status in CEIC and is reported by Ministry of Statistics and Programme Implementation. The data is categorized under Global Database’s India – Table IN.GBG001: Population. [COVID-19-IMPACT]

Population: Jammu & Kashmir data was reported at 13.758 Person mn in 2025. This records an increase from the previous number of 13.660 Person mn for 2024. Population: Jammu & Kashmir data is updated yearly, averaging 11.428 Person mn from Mar 1994 (Median) to 2025, with 32 observations. The data reached an all-time high of 13.758 Person mn in 2025 and a record low of 8.406 Person mn in 1994. Population: Jammu & Kashmir data remains active status in CEIC and is reported by Ministry of Statistics and Programme Implementation. The data is categorized under Global Database’s India – Table IN.GBG001: Population. [COVID-19-IMPACT]